George Yancopoulos
$2.22B
as of 07/05/24
About George Yancopoulos
George Yancopoulos is the chief scientific officer of biotech firm Regeneron.
He received his M.D. and Ph.D. from Columbia University and became a professor of biology by age 28.
Regeneron was cofounded by now-billionaire Leonard Schleifer in 1988. Yancopoulos joined the next year.
Yancopoulos led the invention of seven approved drugs and a technology platform designed to invent more.
Yancopoulos owns about 1% of Regeneron stock.
Personal stats
Citizenship
United States of AmericaSource of wealth
PharmaceuticalsResidence
Yorktown Heights, New YorkMarital status
DivorcedBirth date
09/10/59 (age 64)Number of children
2Education
Medical Doctor, Columbia University; Ph.D, Columbia UniversitySelf-made
self-madeGeorge Yancopoulos’s fortune is worth
37K
troy ounces of gold
34K
median U.S. household
22K
median U.S. income
0.044%
U.S. credit card volume
0.009%
GDP of the United States
0.007%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
Yancopoulos was a finalist in the Westinghouse Science Talent Search in 1976. Today, it is called the Regeneron Science Talent Search and sponsored by his company.
Net worth over time
Real-time ranking
Financial assets
NASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsNASDAQ | REGN-US
Regeneron PharmaceuticalsImages © Forbes.com. All rights reserved.